Cargando…
Targeting the Ghrelin Receptor as a Novel Therapeutic Option for Epilepsy
Epilepsy is a neurological disease affecting more than 50 million individuals worldwide. Notwithstanding the availability of a broad array of antiseizure drugs (ASDs), 30% of patients suffer from pharmacoresistant epilepsy. This highlights the urgent need for novel therapeutic options, preferably wi...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773216/ https://www.ncbi.nlm.nih.gov/pubmed/35052733 http://dx.doi.org/10.3390/biomedicines10010053 |